Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.
- Published In:
- Nature medicine, 6(10), 1167-75 (2000)
- Authors:
- Bielekova, B, Goodwin, B, Richert, N, Cortese, I, Kondo, T, Afshar, G, Gran, B, Eaton, J, Antel, J, Frank, J A, McFarland, H F, Martin, R
- Database ID:
- RPEP-00580
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-00580APA
Bielekova, B; Goodwin, B; Richert, N; Cortese, I; Kondo, T; Afshar, G; Gran, B; Eaton, J; Antel, J; Frank, J A; McFarland, H F; Martin, R. (2000). Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.. Nature medicine, 6(10), 1167-75.
MLA
Bielekova, B, et al. "Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.." Nature medicine, 2000.
RethinkPeptides
RethinkPeptides Research Database. "Encephalitogenic potential of the myelin basic protein pepti..." RPEP-00580. Retrieved from https://rethinkpeptides.com/research/bielekova-2000-encephalitogenic-potential-of-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.